Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Immunoproliferative Disorders
>>
Biogen
>>
Phase 4
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
65
130
195
260
325
390
455
520
585
650
Rituxan
(rituximab) / Roche
Rituxan Hycela
(rituximab/hyaluronidase) / Biogen, Roche, Halozyme
Intron A
(interferon α-2b) / Merck (MSD), Biogen
Zinbryta
(daclizumab) / Biogen, AbbVie